Arecor Therapeutics plc (LON:AREC – Get Free Report)’s share price reached a new 52-week low on Friday . The company traded as low as GBX 50 ($0.63) and last traded at GBX 52 ($0.65), with a volume of 9584 shares changing hands. The stock had previously closed at GBX 54.50 ($0.69).
Arecor Therapeutics Price Performance
The business’s 50 day moving average is GBX 63.99 and its two-hundred day moving average is GBX 72.79. The firm has a market capitalization of £19.63 million, a PE ratio of -1.84 and a beta of -0.18. The company has a debt-to-equity ratio of 5.51, a quick ratio of 6.24 and a current ratio of 1.37.
About Arecor Therapeutics
Arecor Therapeutics plc is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary technology platform, Arestat™, we are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working with leading pharmaceutical and biotechnology companies to deliver therapeutic products.
Featured Stories
- Five stocks we like better than Arecor Therapeutics
- Health Care Stocks Explained: Why You Might Want to Invest
- Symbotic Shares Down 37%—Is It Time for Bravery or Caution?
- 3 Small Caps With Big Return Potential
- High-Yield Healthcare: 3 Stocks With Strong Dividends
- Trading Halts Explained
- Beyond the Bargain Bin: 3 Stocks Leading Discount Retail
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
